DV
Protagonist Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rusfertide (PTG-300) | Polycythemia Vera | Phase 3 |
| Icotrokinra (JNJ-2113) | Moderate-to-Severe Psoriasis | Phase 3 |
| PN-881 | Psoriasis, Psoriatic Arthritis, Hidradenitis Suppurativa, Spondyloarthritis | Phase 1 |
| PN-477sc | Obesity & Associated Co-Morbidities | IND-Enabling |
| PN-477oral | Obesity & Associated Co-Morbidities | IND-Enabling |
| Oral Hepcidin | Polycythemia Vera, Hereditary Hemochromatosis | Pre-clinical |